P. falciparum malaria is still among the leading causes of child mortality in sub-Saharan Africa; killing hundreds of thousands of children each year. Malaria has been recognized as one of the prominent evolutionary selective forces of human genome that led to the emergence of multiple host protective polymorphisms associated with minimizing the risk of developing severe malaria in endemic areas. A comprehensive understanding of the genetic bases of malaria resistance can shed light to the molecular mechanisms of hostparasite interactions that can potentially pave ways to the development of new therapeutics and vaccines. Genome-wide association studies (GWASs) have recently been implemented in malaria endemic areas and identified a number of novel association genetic variants.
Introduction
Plasmodium falciparum, the causative agent of the severe malaria, has been infecting humans for at least 5000-10,000 years following the advent and expansions of agriculture [1] [2] [3] . Malaria still poses a huge social, economic and health problems in several low-income countries, particularly in sub Saharan Africa 4, 5 . P. falciparum infects millions and kills hundreds of thousands of African children each year. However, this constitutes only small proportion (1%) of the populations in endemic areas in which the infections progress to severe malaria such as profound anemia or cerebral malaria 6, 7 . The genetic basis of such variations in malaria disease severity in endemic areas is mainly unclear as the well-known Mendelian variants only explain 2.5% of heritability of malaria protections 8 .
Comprehensive understanding of the genetic basis of resistance and susceptibility to severe malaria is crucial to understand molecular mechanisms of host-parasite interactions that can inform the development of effective therapeutics, vaccination, diagnostics and risk prediction strategies 8, 9 . In a broader context, the findings from malaria susceptibility studies may also provide new insight to human physiology and genetic susceptibility to other common diseases because 'malaria is one of the strongest evolutionary forces that shape human genome polymorphisms 9 .
To better understand the underlying genetics, GWASs have recently been implemented in malaria endemic areas and replicated the well-known variants including HbS and ABO blood group [10] [11] [12] [13] . Despite this success, only few novel variants were identified; suggesting that some of the true association signals might have been attenuated. Which may be resulted from several confounding factors such as: the high genetic diversity of population in malaria-endemic areas, differences in frequencies and effect sizes of protective alleles across populations and the inherent limitations of GWAS approaches among others.
One interesting observation in these studies is the identification of several association signals distributed across the genome that didn't pass GWAS significance threshold;
suggesting the existence of polygenic effects [10] [11] [12] [13] . This raises several key questions including 1) What is the genetic architecture of malaria protection? 2) What is the contribution of polygenic effects? 2) What is the proportion of heritability explained by cell-types, chromosomes, functional groups and molecular pathways? 3) What is the extent and pattern of epistasis and pleiotropy at genome wide scale?
Here we review the current status of malaria susceptibility GWASs and provide guidance to future research directions. We begin by assessing the progress, pitfalls and opportunity of malaria susceptibility GWASs. We then provide an overview of the recent progresses in post-GWAS approaches and discuss how these methods can be implemented in Malaria susceptibility studies to better understand the underlying biology. We conclude by discussing on research areas where further works are needed in light of the global malaria eradication efforts.
Malaria susceptibility GWASs: progress
The GWAS approach is continuing to provide unprecedented successes in genetic studies of wide ranges of complex-traits and common diseases 14, 15, 16 . In malaria susceptibility studies, GWAS approach was initially planned to address the acute limitations of the conventional studies, approaches such as candidate gene and linkage analysis that have been implemented in malaria research for more than two decades 1, 17 .The candidate gene-based studies [18] [19] [20] and the family based linkage studies 21, 22 have identified several genomic loci associated with malaria susceptibility/resistance. However, the majority of the findings were discordant and failed to be replicated in different populations; mainly because of the their limited power 1 . Thus, in view of understanding the genetic basis of malaria susceptibility and resistance at genome wide scale, a global partnership of malaria researchers, named as Malaria Genomic Epidemiology Network (MalariaGEN) 17 , has been established and successfully conducted multi-center-scale GWASs [10] [11] [12] [13] .
The GWASs have replicated the well-known variants including HbS and ABO blood groups which reinforce the importance of erythrocyte variants for protection against severe malaria.
Besides, the GWASs have identified novel association variants (Table 1) that may directly or indirectly influence the disease outcome. The epidemiology and biology of the wellknown variants were reviewed else-where 1 . Below we characterize the novel malaria susceptibility genetic variants identified by GWASs. We first discuss the biology of two variants such as ATP2B4 and cluster of the glycophorin genes (GYPA/B/E) that were convincingly associated and independently replicated across malaria endemic populations and extend our discussion to other potential association signals which didn't replicate and/or did not reach the GWAS significance threshold.
Novel association variants

ATP2B4
The association of ATP2B4 gene with severe malaria was first identified by Timmann et al. 11 in Ghanaian populations. In this study, several SNPs within the ATP2B4 gene, located on chromosome 1q32 showed significant associations. The protective role of the variants of ATP2B4 gene was subsequently reported in other studies 12, 23 . ATP2B4 encodes a ubiquitous plasma membrane calcium-transporting ATPase4 (PMCA4b) 24 . PMCA4b is widely expressed in the majority of human tissues and is the main transporter of Ca 2+ in erythrocyte membrane 24 . A recent study showed that individuals who have a previously unrecognized haplotype named as 'haplotype 1' in their ATP2B4 gene exhibit a reduced PMCA4b expression level 25 . Several SNPs implicated in malaria protection are localized in this haplotype. Timmann et al 11 . proposed that the disturbance of intracellular Ca 2+ homeostasis caused by impaired PMCA4b regulation might play an important role in interfering with pathological effects of malaria in different tissues. The disturbance of intracellular Ca 2+ homeostasis in RBCs might impair the parasite development and reproduction in a parasitophorous vacuole membrane (PVM) 26 . The dis-regulation of intracellular Ca 2+ in other tissues such as placenta, platelets and brain might modify the adhesion phenotypes and hence minimize adhesion-associated pathologies 27 .
Protective mechanisms of ATP2B4 variants might also be associated with impaired regulations of nitric oxide (NO), one of the important molecules in malaria pathogenesis and protections 28, . Increased level of NO was implicated in protection against cerebral malaria while it increases the risk of uncomplicated malaria 29 . In neuronal cells, PMCA4 modulates the activity of neuronal nitric oxide synthesis (nNOS) which in turn regulates NO bioavailability in calcium dependent fashion 30 . Thus, the reduced production of PMCA4 might affect the activities of the nitric oxide synthesis enzyme in the brain which might affect the concentration of NO and hence protection against severe malaria.
Cluster of the 3 glycophorin genes (GYPA/B/E)
The largest multi-center malaria susceptibility GWAS which included eleven populations was conducted by Band et al. 12 . In this study, 34 genomic regions containing potential susceptibility loci for severe malaria were identified. Among which, a strong signal was observed at locus between FREM3 gene and cluster of 3 glycophorin genes (GYPA/B/E) on In addition to the signals near glycophorin genes, six other putative loci that play key roles in membrane biology were identified in this study. A subsequent study in the same populations identified a large number of copy number variants which are characterized by deletion, duplications and hybrid structures in GYPA and GYPB genes 31 . Of which a distinct variant called DUP4 was reported to reduce the risk of severe malaria by about 40% in eastern African (Kenya) populations. Further characterization showed that, this variant is composed of complex GYPB-A hybrid and encode Dantu antigen in MNS blood group system 31 . The association of this region with severe malaria was supported by another recent study in Tanzanian populations 32 . The glycophorin gene cluster, GYPA and GYPB encode the MNS blood group system and are known to be receptors for P.falciparum during RBC invasion 33 . GYPA and GYPB serve as an erythrocyte membrane receptor for EBA-175
and EBL-1 proteins of the parasite respectively 34 . This genomic region is also known to be under an ancient selective pressure resulted from host-pathogen arm races between P.falciparum and humans 35 . Further functional analysis is required to better understand how these variants affect the invasion and/or development of the parasites in erythrocytes and convey protection against severe malaria.
Notable novel association variants
SCO1 and DDC
Notable association signals were identified by the first malaria susceptibility GWAS conducted in Gambian population 10 . The first lead SNP (rs6503319) is located close to SCO1 (synthesis of cytochrome c oxidase) gene on chromosome 17p13. SCO1 is a multifunctional signaling protein which plays an essential role in mitochondrial cytochrome c oxidase (COX) copper delivery pathways 36 . COX catalyzes electron transfer from reduced cytochrome c to oxygen and is abundantly expressed in muscles, brain and liver 36 .
Deficiency of COX caused by mutations in SCO1 gene can lead to respiratory distress and severe metabolic acidosis 37 which are also the major complications during cerebral malaria 38 . Further studies are needed to understand how the variants in SCO1 gene are associated with the pathological pathways of cerebral malaria.
The second notable association signal identified in this study was Dihydroxypheny-alanine decarboxylase (DDC) on Chromosome 7p12.2. A recent study in Tanzanian populations replicated the association of DDC variants with cerebral malaria 32 . DDC gene encodes Aromatic-L-amino-acid decarboxlase enzyme which is involved in biosynthesis of neurotransmitters such as dopamine and serotonin 39 . DDC is an essential enzyme for brain and nervous developments and its deficiency is associated with reduced cognitive functions 39 . DDC is involved in cellular immunity and contributes in protection against parasitic disease in invertebrates 40 . Furthermore, mutations in DDC gene was reported to be associated with refractoriness of Anopheles gambiae mosquito against P.falciparum parasites 41
MARVELD3
In addition to the ATP2B4, Timmann et al. 11 identified an association SNP (rs2334880) on chromosome 16p 22.2 which is linked to MARVELD3. However, this association has not been replicated in other studies. MARVELD3 is one of the components of tight junction proteins in several epithelial and endothelial tissues and is expressed as two alternative spliced variants 42 . These proteins are involved in assembly, development, maintenances and regulations of tight junction. Tight junctions play a major role in intracellular adhesions and involved in sub-cellular signaling mechanisms 42 .
IL-12 receptors and IL-23 receptors
The most recent malaria susceptibility GWAS was conducted in Tanzanian population 13 . In this study, notable associations signals were identified in immune pathways including in interleukin receptors (IL-23R and IL-12RBR2), in ketch-like proteins (KLHL3) and Human Leucocyte Antigen (HLA) regions. Interlekuen-12 is formed from a hetrodimer of IL12B (ILp40 subunit) and IL-12A (ILp35 subunit) 43 . IL-12 plays a vital role in stimulating cellmediated immune response against intra-cellular pathogens through binding to high affinity IL-12RB1 and IL-12RBR2 receptor complexes. It promotes the development of T-helper cells (Th1) and enhances the production of INF-γ, which are known to mediate the clearance of intracellular pathogens 43 . In malaria, IL-12 has been implicated in mediating the protective immunity both in experimental animals and humans 44 . IL-23 is an important proinflammatory cytokine that shares p40 subunits with IL12 45 . It induces the differentiation of naive CD4 T-cells to IL-17 which plays key roles in pathogenesis of autoimmune diseases 46 .
HLA is encoded by the Major Histocompatibility Complex (MHC), the most polymorphic genes known in human genome. The diversity of MHC is believed to be driven by selection pressure from infectious pathogens and known to be associated with the risk of several infectious diseases 47, . HLA variants such as HLA class I antigen (HLA-Bw53) and HLA class II variant (DRB1*1302-DQB1*0501) were reported to confer protections against severe malaria in Gambian populations 47 . HLA class I antigen is expressed by liver cells suggesting that T cells (CTL) responses might efficiently act against the liver stage of malaria parasite in individuals with HLA-Bw53 47 . Similarly, individuals with DRB1*1302-DQB1*0501 variant might possess efficient antigen presentation mechanism that can lead to rapid clearance of blood stage parasite 47 .
Variants in immune pathways are of great interest because of their potential to inform the development of effective malaria vaccines 1 . The current study is interesting in that several putative variants in immune pathways were identified. However, the power of this study is limited because of relatively smaller sample size and weak significance threshold used to interpret the findings. Therefore, further studies with higher detective power are needed to consolidate the findings. 
Challenges of malaria susceptibility GWASs
Despite its promising progress, GWAS approach has several limitations including 1) Weak performances in genetically diverse populations 8 , lack of translation of associated loci into suitable biological hypotheses 16 , 3) the well-known problem of missing heritability 15 , 4) the lack of understanding of how multiple modestly associated loci within genes interact to influence a phenotype 48 , 5) inefficiency in distinguishing between inflation from bias (cryptic relatedness and population stratification) and true signal from polygenicity 49 , 6) the imperfection of asymptotic distribution of current mixed model association or logistic regression in the specific case of low-frequency variants 50 . The discussion on limitations of GWAS approaches is beyond the scope of this review. Here we focus on the major challenges of malaria susceptibility GWASs and highlight recent positive progresses.
Dealing with genetic diversity of African populations
There is high level of genetic diversity and weak linkage disequilibrium (LD) in Africans compared to non-African populations 51, 52 which is believed to be due to adaptation to diverse climate, diet and response to infectious diseases such as malaria and tuberculosis 51, 53 . These distinct genetic characteristics created major setbacks to GWASs in African populations 8 . The fundamental rationale of the GWAS is a 'common disease common variant' hypothesis which predicts that common diseases are influenced by common genetic variants that are prevalent in higher frequencies in the populations 16 57 is also an additional resource that can facilitate genomic analysis in populations of African ancestry. The improvement in reference panels have facilitated imputation-based studies in African populations. For instance, Band et al. 9 showed the feasibility of multi-point imputation based meta-analysis in for malaria GWASs using
HapMap3 haplotype panel. However, imputation accuracy was relatively lower compared to that of European populations. Another study showed a substantial improvement of imputation accuracy by using the more diversified AGVP WGS reference panel 52 . The reference dataset is expected to grow further and accelerate genomic research by including wide range of haplotype diversity in African populations.
Sample size
In GWAS, a stringent p-value (1x10 -8 ) is usually needed to declare evidences of genuine associations to minimize false discovery rate that can arise from multiple testing. 58 Thus, very large sample size is required to achieve genome-wide significance threshold particularly for loci with modest effect sizes. The required sample size is even much higher for studies in population of African ancestry because of the higher genetic diversity.
However, the sample sizes of GWASs in African populations are generally small compared to non-Africans 59 .
In malaria susceptibility GWASs, the success rate of identifying significant associations seems to be a function of sample sizes. in the first Malaria GWAS 10 that involved 2500 children, none of the association signals passed the GWAS significance threshold; whereas in the subsequent GWASs that involved relatively larger sample sizes 11, 12 , novel association variants were convincingly identified. To this effect, MalariaGen consortium has increased the sample size and included more study populations in its recent GWASs 12 .
However, one of the challenges of the MalariaGEN dataset is that the sample sizes obtained from each study population is limited; making it difficult to undertake separate GWASs for specific geographic areas. Allelic heterogeneity of the malaria protective variants is very 
Genetic architecture of malaria susceptibility/resistance
The performance of GWASs is dependent on the genetic architecture of the disease/trait under investigation. For the majority of complex diseases/traits, the GWAS variants identified thus far, only explain a very small proportion of heritability; a phenomenon commonly termed as 'missing' heritability 15 . There have been different explanations for the 'missing' heritability including common disease rare variant hypothesis 61 , none-additive components, primary epistasis 62, 63 and polygenic genetic architecture 16 .
One of the challenges of malaria GWASs is that we don't know much about the genetic architecture of malaria protection trait. First, as one of the prominent evolutionary selective forces, the majority of malaria protective alleles might have evolved under positive selection and might potentially be balanced by other forces 64 
Polygenic architecture and epistasis: Presenting the absent in the current malaria
GWASs
Polygenic genetic architecture
Polygenic view of genetic architecture is gaining ground in genetic epidemiological studies and widely implicated for the 'missing' of heritability in GWAS analysis 67 . The rationale behind polygenic inheritance is that complex-traits/diseases are influenced by multiple variants with modest effects that are too small to pass the stringent genome wide significance threshold 68 . In standard GWAS analysis, 'Genomic control' (GC) method is applied as a quality-control measure to minimize spurious associations that can be caused by population structures such as population stratification and cryptic relatedness.
However, a slight inflation of the test statistics which cannot be corrected by GC was
initially observed across the genome in a Schizophrenia GWAS 69 . Subsequently, this observation has been supported by other studies 70 SNPs. The detail of this approach is explained in Purcell et al. 69 . The MLM approaches, that jointly accounts for fixed and random effects, is becoming a standard method for estimating heritability of complex diseases/traits. Yang et al. 70 introduced an elegant method that builds genetic relationships matrix (GRM) of unrelated individuals by simultaneously fitting all SNPs and estimates the proportion of phenotypic variations explained by genotypic variation using restricted maximum likelihood (REML) method. Variations of MLM approaches with different flavors have subsequently been published and implemented for estimating and stratifying heritability of complex traits/diseases in to chromosomes, functional groups and pathways [74] [75] [76] . The use of unrelated individuals has an advantage of minimizing the bias from shared environments in pedigree studies.
Another approach is LD score regression method 77 . The rationale of this approach is that there are three sources of variations in GWAS estimates such as true signals, population structure and estimation errors. The LD score regression effectively decomposes these components by exploiting the LD strength of a given SNP with other SNPs. The marginal association is higher for SNPs that are in LD with several variants. The detailed description of the polygenic analysis methods is reviewed in 67 .
Polygenic contributions in malaria susceptibility/resistance
Co-evolution of host-pathogen model predicts that multiple host loci are involved in resistance/susceptibility to infectious diseases due to the complex interactions between the multi-locus parasite genotype and the corresponding defense from the host-genome 63, 78 .
Indeed, malaria might have left multiple genetic variants; the majority of which have effects too small to be detected by the standard GWASs. The existence of polygenic inheritance in Thus, implementation of polygenic analytic methods in malaria studies may potentially shed more light to the underlying biology. For instance, heritability can be estimated and partitioned in to different cell-types and functional groups and molecular pathways which enable to localize causal variants. Furthermore, these approaches can be extended to explore genetic correlation between susceptibility to malaria and to other infectious diseases. The existence of shared genetic basis between infectious diseases susceptibility/protection is well-documented , 79 . However, the extent and pattern of genetic correlation has not been systematically investigated at genome-wide scale; partly because of inadequate GWAS data for infectious diseases. Such studies can potentially provide clues to common molecular processes between resistance/susceptibility to infectious diseases that will have practical importance such as: designing multi-purpose vaccine and genetic risk prediction strategies.
Heritability of severe malaria in Gambian population
To figure out how polygenic analysis can be implemented in malaria susceptibility, we accessed the Gambian malaria susceptibility GWAS dataset from European Phenome Genome Archive (EGA) through data application procedure and estimated heritability of malaria susceptibility using MLM approaches. The Gambian GWAS data is the largest MalariaGen dataset obtained from a single country comprised of 4920 samples (2429 cases and 2491controls) and 1.6 million SNPs that passed GWAS quality control (QC). We first excluded the known malaria susceptibility associated loci and performed stepwise extra QC filtering. Specifically, we focused on sample relatedness, SNP missingness proportion and SNP differential missing proportion which are well-known to affect the accuracy of heritability estimation 75 . We then estimated the heritability using GCTA model for different QC thresholds by including 10 principal components (PCs) as fixed effects to account for population structure. As expected, the estimation is highly unstable when less stringent QC thresholds is applied (varying from 37.8% to 20.1%) as shown in Table 2 . However, when more stringent QC (Relatedness threshold (5%), SNP differential missingness proportion (p < 1x 10 -3 ) and SNPs missing proportion of (p>0.02)) is applied, the estimation became stable (~20.1%, SE =.07). Neither the inclusion of more PCs (15, 20) Larger sample size is needed to further partition the heritability explained by cell types and functional groups.
Although our heritability estimation is fairly stable when stringent QC is implemented, care should be taken in interpreting these results: First, all polygenic methods perform better in less structured data obtained from homogenous populations than the MalariaGen dataset which is comprised of diverse populations spanning most of the Malaria endemic belt in Africa. Second, the methods are designed and perform well in highly polygenic traits/diseases in which effects of each variant is mostly modest. However, a significant proportion of malaria protection trait might be attributed to rare variants of large effect sizes that might not be in LD with common variants and can't not be 'tagged' by SNPs chip. The contribution of such variants will not be accounted for in the estimation. Third, subtle population structure that cannot be corrected by conventional methods such as unmatched case/control can potentially create systematic biases to the estimate. Fifth, the controversy between the performances of different methods is still continuing and there is no gold standard method against which the accuracy of these models can be evaluate 
Epistasis
Epistasis is becoming one of the hot research topics in genetic epidemiological studies in the last few years because of the fact that none additive genetic variations are shown to have significant influence on the phenotype of complex traits/diseases than previously expected 80 .
The available statistical approaches and software packages for detection of epistasis at genome-wide scale are reviewed elsewhere 80, 81 . These approaches have been applied in genetic studies of complex diseases such as lupus erythematosus 82 , anklosing spondlylitis 83 , psiorosis 84 and unraveled previously unknown epistasis interactions between risk loci which explained a significant proportion of 'missing' heritability of the respective diseases.
Epistasis between malaria risk loci have been well documented and implicated as one of the possible reasons for lack of replication of susceptibility variants in different populations and the 'missing' heritability. For instance, sickle-cell trait (HbS) and α thalassaemia were shown to demonstrate negative epistatic interactions such that the protection against severe Malaria offered by HbS is reduced when co-inherited with α+ thalassaemia 85 .
A case-control study in Kenyan population also reported that α+ thalassaemia modulates the effects of Haptoglobin (Hp) variants in predicting the risk of severe malaria 86 . In this study, it was shown that the combination of α+ thalassaemia and Hp2-1 variant synergistically increase the protection against severe malaria by about 37%. However, the protective effect is decreased to 13% when α+thalassaemia is inherited with Hp1-1 and further diminished to neutral (zero) when inherited with Hp2-2. Similarly, in a multi-center case control study, the existence of negative epistasis interaction between HbC and ATP2B alleles was reported 18 .
Another recent case control study of severe malaria in Kenya reported the existence of negative epistasis between a compliment receptor called S12 and α+thalassaemia in which the protective effect of S12 higher in children with normal α-globin 87 . The extent and pattern of epistatic interaction at genome-wide scale is yet to explored. In malaria susceptibility GWAS, the priority has been given to a single locus analysis to identify novel risk loci. We expect that, the next step of Malaria susceptibility GWAS will be the considerations of epistasis.
From GWAS to biology: multi-step and multi-dimensional analysis
Fine-mapping and pathway analysis
The ultimate goal of genetic susceptibility studies is to identify the causative variants and understand the underlying biological pathways which can lead to translated medicine such as effective vaccines and therapeutics. However, translating GWAS signals in to biological
themes remains an open problem because of the confounding effects from LD between association SNPs, limited knowledge of gene functions and localization of the majority of GWASs hits in none protein coding regulatory regions (regulatory SNPs) [88] [89] [90] . In attempt to address this challenge, several fine mapping strategies have been developed and implemented 91 . One such strategy is trans-ethnic fine mapping in which the natural variability of haplotype structure across ethnically diverse populations is used to narrow down the candidate causative variants 92 . The smaller LD and diversity of haplotype structure in African population makes it relatively easier to identify the causal SNPs and target gene/genes through fine mapping approaches 8 . However, the fact that malaria protective alleles are heterogeneous across populations might challenge the application of trans-ethnic finemapping approaches in malaria susceptibility studies.
Alternatively, several fine mapping statistical tools have recently been developed following the advances in annotation data bases and improved reference panels. These include Bayesian approach, heuristic approach and penalized regression methods 93 . The principles, applications, strength and weakness of these methods is reviewed elsewhere 91, 93 . These methods are increasingly playing crucial role in the efforts being made to pinpoint causal variants of complex diseases/traits. For instance, Galarneau et al. 94 Similarly, a recent fine mapping study of HLA region identified several susceptibility loci for multiple infectious diseases 79 . More sophisticated studies that combine statistical and functional fine-mapping strategies have recently been implemented and provided mechanistic insights to the genetic basis of complex diseases 95 In addition to fine mapping approaches, pathway and interaction analysis can be another avenue for exploring molecular basis of Malaria susceptibility/resistance. Instead of emphasizing on single-variant analysis, these approaches test the coordinated effects of several variants at systems level using biological information from annotation data basis 96 .
Pathway analysis improve study power by integrating cumulative effects of weak association signals and provide functional information by identifying associated sets of genes/proteins 97 . By implementing the pathway analysis approaches, several studies have gained new insights in understanding the genetic basis of complex diseases [98] [99] [100] .The available statistical tools for pathway and interaction analysis is reviewed in 101 .We therefore, advocate for the implementation of fine mapping and pathway analysis in malaria susceptibility studies to shed more light to the underlying biology.
Multi-omics approaches
Today, there are significant advances in high throughput technologies that can generate big '-omic' data from all spectrum of molecular biology 88 . The '-omics' studies (Genomics, Epigenomics, Transcriptomics, Proteomics, Metabolomics) are crucial to understand the underpinning biology of complex diseases.
In severe malaria, '-omics' studies have provided important clues about the molecular events that lead to either complications or recovery from diseases. For instance, following the discovery of glycophorin regions by the GWAS, a targeted sequencing-based study 31 was conducted to characterize variants in this region and identified a novel distinct copy number variant called DUP4 which reduces the risk of severe Malaria by about 33% . In addition to this, a genome-wide gene expression study was conducted in Kenyan children in which increased expression of genes related to neutrophil activation during malaria infections was shown 102 . The authors also observed differential expression of heme-and erythrocytesrelated genes in acute malaria patients which reaffirms the importance of erythrocyte-related genes in malaria susceptibility/resistance.
In another host-parasite interaction study, the importance of miRNA in inhibiting parasite growth in erythrocyte was reported 103 . The authors observed translocation of several host RBC miRNAs in to P. falciparum parasites, as well as fusion of these human miRNAs with parasite mRNA transcripts to inhibit the translation of enzymes that are vital for the parasite development. Specifically, two micro-RNAs, miRNA-451 and let-7i, were highly enriched in HbAS and HbSS erythrocytes and these miRNAS along with miR-223 were shown to attenuate the growth of parasite 103 .
However, '-omics' studies are limited to single data-type analysis and lack adequate power to explain the complexity of molecular processes and usually lead to identification of correlations than causations 104 . Thus, integrating and analysing multiple '-omics' data enables better understanding of the molecular processes and interactions that give rise to complex diseases/traits. For example, leveraging host microbiome relative abundance data as a second (quantitative) trait, and performing a joint analysis of bivariate phenotypes can increase statistical power by maximizing phenotypic information and inform how the interaction between host genotype with microbiome impacts the phenotype.
Multi-omics approaches aim to integrate big '-omics' data, undertake 'multi-step' and 'multidimensional' analysis for elucidating complex biological problems 104 . Driven by the massive abundance of '-omics' data from wide ranges of biological molecules, multi-omics strategy have recently provided unprecedented successes in complex diseases/trait studies.
The current state of art of multi-omics approach and available statistical methods is recently reviewed in Hasin et al. 104 Malaria susceptibility/resistance is influenced by several host, parasite and environmental factors as depicted in Figure 1 . The protective alleles have independently evolved in different populations being shaped by the co-evolution and interaction between the human genome, the parasite and environment 1 . So far, single '-omics' data analysis enabled us to understand some of the factors that are associated with the malaria protective traits. To progress beyond associations and pinpoint the causal pathways, it may require to implement carefully designed, coordinated multi-omics studies that involve human host, the parasite, the environment and possibly mosquito. The current advents of high-throughput technologies in generating massive '-omics' data and their continuously decreasing cost complemented with the availability of statistical tools which able to simultaneously capture millions of data points will lead to the implementations of multi-omics approaches in malaria susceptibility studies. Another challenge is that we don't know much about the genetic architecture of malaria protective trait. There are two scenarios in which GWAS approach might fail. First, malaria protective trait might largely be attributed to rare variants of large effect sizes that might not be in LD with common variants and can't not be 'tagged' by SNPs chip. Second, malaria might have left multiple genetic variants distributed across human genome; the majority of which have effects too small to be detected by the standard GWASs 1,7 . Theoretically, the large sample sizes, dense genotyping chips, use of appropriate reference panels and effective genotype imputation can address the majority of challenges. However, given the resource constraints; especially, in Africa where malaria problem is the greatest, this will likely take several years to achieve.
On the other hand, the recent advances in statistical techniques is enabling to extract useful information from the present-day GWAS sample sizes. For example, a number of statistical approaches have been developed to capture polygenicity in complex diseases. We showed how these methods can potentially be implemented in malaria susceptibility studies and provide useful insights. We believe that further studies with larger sample sizes can elucidate the polygenic effects in malaria protective trait by extending the analysis to genome partitioning, risk prediction and genetic correlations.
Beyond singe locus analysis, multi-step and multi-locus analysis including pathways analysis, fine mapping and interaction analysis can potentially be implemented in malaria susceptibility GWASs to gain new insights to the underpinning biology. For instance, pathway analysis can provide important information by analyzing the coordinated effects of several variants at systems level using biological information from annotation data basis.
Fine mapping strategies that combine statistical and functional fine-mapping strategies can potentially be implemented to pinpoint the causal variants from the GWAS association signals.
Most importantly, the future direction of malaria susceptibility requires a paradigm shift from single '-omics' to 'multi-stage' and 'multi-dimensional' integrative functional studies that combines multiple data types from the human host, the parasite, the mosquitoes and the environment. The current biotechnological advances, an ever-increasing annotation data bases and availability of advanced analytical techniques, will eventually lead to feasibility of systems biology studies and revolutionize malaria research.
